FindTrial
Sign In

COVID-19 Induced Autonomic Dysfunction Increases Tumor Risk

COVID-19 Induced Autonomic Dysfunction Increases Tumor Risk

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098809
Enrollment
Unknown
Registered
2025-03-13
Start date
2025-03-13
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer ?Autonomic Nervous System Dysfunction ,ANSD

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age:18-80; 2.Complete the autonomic nervous function scoring examination.

Exclusion criteria

Exclusion criteria: 1.Autonomic nervous function data is missing or has been repeatedly tested. 2.Tumor/No tumor data is missing, and there is loss to follow-up.

Design outcomes

Primary

MeasureTime frame
Autonomic Dysfunction;—

Countries

China

Contacts

Public ContactPeng Lei

The First Affiliated Hospital of Chongqing Medical University

1776786085@qq.com+86 755 28637132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026